News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looking sweet this morning
GO VRNM !!!
VRNM looking sweet
I'll let the charts do the talking
CAMBRIDGE, Mass., Feb 01, 2010 /PRNewswire via COMTEX/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has extended the initial 18-month joint development program established in August 2008 with partner BP, which was scheduled to expire on February 1, 2010, until March 1, 2010. BP and Verenium will continue their ongoing joint development work to accelerate the development and commercialization of cellulosic ethanol, while the two parties continue to negotiate the terms of a multi-year extension of their collaboration program. Verenium will receive an additional $2.5 million from BP to co-fund various scientific and technical initiatives for the month of February.
"We are very pleased with the success we've had over the 18-month Galaxy collaboration and are enthusiastic about expanding this technology development partnership with BP. We continue to focus on our vision for evolving cellulosic ethanol as a viable solution to complement our energy needs," said Carlos A. Riva, President and Chief Executive Officer at Verenium.
The material terms of this amended agreement are described in more detail in the Company's Current Report on Form 8-K filed on February 1, 2010 with the Securities and Exchange Commission. The Company expects to announce the outcome of negotiations with BP to further extend their collaboration program within the coming weeks.
Its been a long time since their last PR...
Feb 1, 2010 Verenium and BP Extend Galaxy Joint Development Program
Nov 9, 2009 Verenium Reports Financial Results For The Third Quarter 2009
Nov 3, 2009 Verenium and Syngenta Close Research Collaboration
Nov 3, 2009 Verenium Corporation to Present at the Thomas Weisel Partners Alternative Energy & Natural Resources Conference
Nov 2, 2009 StockProfiler.US: Stock Watch: PRXL, NVAX, VRNM
Nov 2, 2009 Verenium to Announce Third Quarter 2009 Financial Results
---
Item 1.01 Entry into a Material Definitive Agreement.
On January 29, 2010, Verenium Biofuels Corporation (“Verenium Biofuels”), a wholly owned subsidiary of Verenium Corporation, entered into an amendment of the existing Joint Development and License Agreement with BP Biofuels North America LLC (“BP”) dated August 6, 2008, focused on the development and commercialization of cellulosic ethanol technologies. The principal purpose of this Amendment No. 1 to Joint Development and License Agreement (the “Amendment”) was to extend the term of the original 18-month joint development program by one month, to March 1, 2010 (the “Extended Term”).
The financial terms of the Amendment include a cash payment of $2.5 million to Verenium Biofuels by BP on February 5, 2010 for the continued performance of Verenium’s obligations under the joint development program during the Extended Term.
On February 20, 2009, Verenium Biofuels and BP also became parties to an Amended and Restated Limited Liability Company Operating Agreement whereby they each own a 50% interest in a limited liability company, Highlands Ethanol LLC, that serves as a commercial entity for the deployment of cellulosic ethanol technology being developed and proven pursuant to the Joint Development and License Agreement referenced above. The Amendment and Extended Term referenced above have no effect on Highlands Ethanol LLC.
welcome to the boards up-down, thanx for posting the charts.
Vrnm had a few bad over at the end of last week (as did the rest of the markets, tahnx to a certain somebody who can't seem to keep his mouth shut...) and its looking to be a bit over-sold to me. This thing is due for a good day.
On the bright side, at least you were able to find it while it was on sale! 
VRNM OS: 11.7M on 11/06/2009
Common Stock outstanding as of November 6, 2009 was 11,715,228
250,000 shares authorized, 9,428,000 and 5,648,000 shares issued and outstanding at September 30, 2009
on September 9, 2009, the Company effected a reverse stock split of the outstanding shares of its common stock, with a par value of $0.001 per share, on the basis of one (1) new share of common stock for each 12 shares of common stock then outstanding.
Public Offering of Common Stock and Warrants
on October 6, 2009, the Company issued 2,250,000 shares of its common stock and warrants to purchase an additional 900,000 shares of common stock in an underwritten public offering at a price of $6.00 per unit, raising net cash proceeds of approximately $12.3 million.
Verenium Corporation engages in the development and production of specialty enzyme products, and production and commercialization of biofuels. It operates in North America, South America, Europe, Asia, and the Middle East. The company was formerly known as Diversa Corporation and changed its name to Verenium Corporation in June 2007 as a result of the merger with Celunol Corp. Verenium Corporation was founded in 1992 and is based in Cambridge, Massachusetts.
Ethanol and Biofuel Stocks ... looking like VRNM is due for a turn at bat!
...consumer electronics retailer turned alternative energy investment company Rex Stores (RSC)
Jan 7, 2010
The ethanol segment has been a hot topic ever since the U.S. EPA made positive comments relating to a recent lobby for E15 gasoline, which if approved, would boost the legal percentage of ethanol in gasoline by 50%.
A look at the Ethanol and Biofuel Stocks Index's six-month performance chart shows that after trading in tandem with the broad markets throughout the third quarter, ethanol stocks broke out in November. Over the last month the sector is mixed, with a bias towards the upside.
Enzyme products specialist Verenium (NASDAQ: VRNM - News) has shot up by 21% over the last month, leading the ethanol and biofuel segment as of yesterday's close. Braillian ethanol and sugar company Cosan (NYSE: CZZ - News) was close behind with a 19% one-month rally.
In today's session, Cosan, MGP Ingredients (NASDAQ: MGPI - News), and Green Plains Renewable Energy (NASDAQ: GPRE - News) are all slipping by more than -1% as the broad market takes a breather.
VRNM chart
How to post a chart... see #msg-45320970
|
Followers
|
11
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1044
|
|
Created
|
11/09/07
|
Type
|
Free
|
| Moderators | |||
This board is for fundamental and technical discussion about Verenium Corporation, VRNM.
Verenium Corporation, formerly Diversa Corporation, is engaged in biomolecule discovery. The Company employs its enzyme discovery and evolution technologies to enable higher throughput and improved environmental outcomes. In addition to its internal and partnered research and development programs, the Company has a portfolio of commercialized enzyme products, as well as several late-stage product candidates. The Company's key areas of focus for internal product development are integrated solutions for the production of cellulosic biofuels, such as cellulosic ethanol, and specialty enzymes for biofuels, specialty industrial processes, and health and nutrition. It has formed alliances with companies, such as BASF, Bunge Oils, Cargill Health and Food Technologies, DSM, DuPont Bio-Based Materials, Syngenta AG, and Xoma, to complement its internal product development efforts. The Company has two inactive subsidiaries: Innovase LLC and TNEWCO Inc.
Verenium Corporation is a leader in the development and the commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as higher performance specialty enzymes for applications within the biofuels, industrial, and animal nutrition and health markets.
The Company possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of cellulosic ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.
Verenium’s Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium’s world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes that act as the catalysts of biochemical reactions.
Verenium operates one of the nation’s first cellulosic ethanol pilot plants, an R&D facility, in Jennings, Louisiana and has recently entered the start-up phase at its 1.4 million-gallon-per-year demonstration-scale facility. In addition, the Company’s process technology has been licensed by Tokyo-based Marubeni Corp. and Tsukishima Kikai Co., LTD and has been incorporated into BioEthanol Japan’s 1.4 million liter-per-year cellulosic ethanol plant in Osaka, Japan -- the world’s first commercial-scale plant to produce cellulosic ethanol from wood construction waste.
Verenium and Marubeni are continuing to advance the commercialization of cellulosic ethanol projects utilizing Verenium’s proprietary technology in Asia with the opening of a three million-liter-per-year plant in Saraburi, Thailand. The cellulosic plant in Thailand is co-located with a facility that will produce ethanol from sugar-cane derived sucrose, which is widely abundant in the region.
Verenium Corporation Verenium Corporation Verenium Biofuels, LLC
55 Cambridge Parkway, 8th Floor 4955 Directors Place PO Box 389
Cambridge, MA 02142 San Diego, CA 92121 11107 Campbell Wells Road
TEL: 617.674.5300 TEL: 858.526.5000 East Highway 90
Jennings, LA 70546
TEL: 337.785.4500
Charts
http://stockcharts.com/c-sc/sc?s=VRNM&p=D&yr=1&mn=0&dy=0&i=p97368207901&a=159379713&r=422
The plant will make ethanol from energy cane, a variety of sugar cane bred specifically for ethanol production.
Verenium owns a robust intellectual property portfolio with patents covering our key technologies in the discovery, optimization, production and use of novel protein-based products. In addition, we maintain numerous composition of matter patents covering our novel enzyme products and product candidates. Verenium currently has over 300 issued patents and over 400 patents pending (as of June 2008).
Selected Patents
5,939,250 Production of enzymes having desired activities by mutagenesis. 5,958,672 Protein activity screening of clones having DNA from uncultivated microorganisms 6,001,574 Production and use of normalized DNA libraries 6,168,919 Screening methods for enzymes and enzyme kits 6,171,820 Saturation mutagenesis in directed evolution 6,280,926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same 6,344,328 Method for screening for enzyme activity 6,455,254 Sequence based screening 6,537,776 Synthetic ligation reassembly in directed evolution 6,632,600 Altered thermostability of enzymes
Verenium Facilities
Located on a 140-acre company-owned site are Verenium’s Pilot and Demostration-scale plants.
Pilot Plant:
Verenium operates a cellulosic ethanol pilot plant, a real-time research and development facility, in Jennings, Louisiana. Opened in 1999, the facility was capable of CF hemicellulose fermentations. During 2006 the company completed extensive upgrades on the pilot facility, enabling it to conduct combined C5 and C6 fermentations. The Jennings pilot facility is capable of processing approximately two tons of biomass per day into ethanol. It is operated as an R&D facility to improve the company’s process technology and to validate the company’s process on a wide variety of biomass feedstocks.
Demonstration Plant:
Next door to the pilot facility, Verenium has recently achieved mechanical completion of a 1.4 million gallon per year demonstration-scale plant - the first of its kind in the nation. Over the next few months, more than forty separate systems will be electronically energized. Operating teams have begun evaluations, and the project will move to validate the implementation of Verenium’s process and technology. By year-end, Verenium will move to fully optimize the demonstration plant.
Commercial Projects:
Preparations are being made for Verenium’s first commercial-scale facilities, which are expected to produce 30 million gallons of ethanol per year. With the optimization of Verenium’s pilot and demo plants, the commercial plant development program is underway. Currently, a variety of sites are being explored for plant development in Florida, Louisiana, and Texas.
Osaka, Japan:
In addition, the Company’s process technology has been licensed by Tokyo-based Marubeni Corp. and Tsukishima Kikai Co., LTD and has been incorporated into BioEthanol Japan’s 1.4 million liter-per-year cellulosic ethanol plant in Osaka, Japan -- the world’s first commercial-scale plant to produce cellulosic ethanol from wood construction waste.
Developing A Pipeline of Commercial Projects Implementing First-Generation Cellulosic Ethanol Technology
Verenium is advancing the strategic development of a pipeline of sites in the Gulf region of the U.S. for its first series of commercial facilities.
Verenium’s Commercial Development team is actively working on developing a series of projects for 30 to 60 million gallon per year commercial-scale cellulosic ethanol facilities in the US Gulf region. Ultimately, the Company plans to expand its development globally, however, its initial focus is in the Gulf region, given the proximity to areas with strong growing conditions for high biomass dedicated energy crops and in some cases sugarcane bagasse.
As projects are being developed, critical areas of activity will focus on site feasibility, permitting, feedstock supply agreements, other commercial agreements, and financing. The current projects that the Company has under development in the Gulf region have the following key attributes:
Energy crops and sugar cane bagasse feedstocks
Local agricultural partners
Good logistical interfaces
Potential options for co-locating with other facilities
Partnerships are key
As the Company continues to develop commercial projects, bringing partners into the mix will be a critical component of the overall strategy. The goals of these partnership arrangements will be to bring additional, specialized skills into the value chain, particularly in the areas of agronomics, engineering and construction, and marketing / off take as a means for helping to both de-risk and accelerate the development of each project.
Verenium expects to continue to advance a pipeline of multiple sites, and to have its first commercial plant ready for construction by the middle of 2009.
ThinkEquityLLC Audio:
http://www.wsw.com/webcast/think/vrnm/
Videos:
http://www.youtube.com/watch?v=itgtacaM_dM
http://www.youtube.com/watch?v=EkrvYfwVaLw
http://www.verenium.com/_about_verenium.asp
New Secretary of Energy on cellulosic ethanol:
http://www.youtube.com/watch?v=V448U2SYU7U
http://www.youtube.com/watch?v=m7RkwcpejAQ
Power Point Presentation:
Posting Rules for the VRNM board!
All posters will be subject to the IHub TOU agreement.
Any messages that violate the User Agreement or detracts from the civility of the board will be removed.
AI
